XFOR
X4 Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.04
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 41.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.58x
- Price / sales
- 25.28x
- Price / cash flow
- -4.78x
Enterprise value
- Enterprise value
- $269.8M
- EV / sales
- 17.03x
- EV / EBITDA
- -3.39x
- EV / EBIT
- -3.07x
- Market cap
- $400.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026